24.07.2015

We are offering for out-licensing 7 generic and 10 dietary supplement product concepts that have innovative attributes (new dosage form, new formulation, new therapeutic indication, etc.) and non-infringement qualities for the Russian/CIS market

14.09.2015

Since June 2016 we are operating from Barcelona office only although fieldwork in Russia & CIS remains in effect on a permanent and full-range basis

14.09.2017

We have finalised to compile a database of overall SNPs for inherited metabolic diseases (Rare Diseases TA)

 
 
 
 
 
 
 
 
 
 
 
 
 
 

Обсуждение закрыто.